Description
Fibron 80 mg contains febuxostat 80 mg, which reduces the production of uric acid by inhibiting xanthine oxidase. It is used in adults with chronic hyperuricaemia associated with gout, including patients with gouty arthritis or tophi.
Febuxostat is a urate-lowering treatment intended for long-term control of serum uric acid. It does not provide immediate pain relief during an acute gout attack.
The usual treatment target is to reduce and maintain serum uric acid below 6 mg/dL (357 µmol/L).
















